CoChat

Nutritional Supplements and Complementary Therapies in Polycystic Ovary Syndrome

Open access
Alesi, Simon, Ee, Carolyn, Moran, Lisa J, Rao, Vibhuti, Mousa, Aya · 2022 · Advances in Nutrition
Cited by 146

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Abstract

Polycystic ovary syndrome (PCOS) affects 1 in 5 women of reproductive age, and is characterized by menstrual irregularities, clinical or biochemical hyperandrogenism, and the presence of polycystic ovary morphology. One of the recommended treatment strategies in the international evidence-based guidelines is lifestyle modification, which includes diet and exercise, with the aim of improving a range of health outcomes. The incurable nature of PCOS reinforces the importance of developing novel and innovative symptomatic relief strategies, which are currently the only available approaches for improving quality of life for these women. Women with PCOS tend to be nutrient deficient in many common vitamins and minerals, thought to be associated with the psychological (depression, anxiety, etc.) and physiological (insulin resistance, diabetes, infertility, etc.) sequelae of the condition. Nutrient supplementation and the integration of complementary medicine as adjuncts to traditional lifestyle-based therapies in PCOS could therefore provide additional benefits to these women. In this review, we synthesize the evidence regarding nutrient supplementation and complementary therapies in PCOS, predominantly from randomized controlled trials, systematic reviews, and meta-analyses, to provide an overview of the state of knowledge in this field. The evidence to date suggests that specific vitamins (B-12, inositols, folate, vitamins D, E, and K), vitamin-like nutrients (bioflavonoids and α-lipoic acid), minerals (calcium, zinc, selenium, and chromium picolinate), and other formulations (melatonin, ω-3 fatty acids, probiotics, and cinnamon), as well as some complementary approaches such as acupuncture and yoga may be beneficial in PCOS. However, there remain areas of uncertainty and key limitations in the literature that must be overcome before these therapies can be integrated into routine clinical practice.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/advances/nmab141

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 47 references

Research works printed but not linked: 150

  1. Apridonidze, 2005, Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome, J Clin Endocrinol Metab, 90, 1929, 10.1210/jc.2004-1045 · DOI · Paper page
  2. Wolf, 2018, Geographical prevalence of polycystic ovary syndrome as determined by region and race/ethnicity, Int J Environ Res Public Health, 15, 10.3390/ijerph15112589 · DOI · Paper page
  3. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group, 2004, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS), Hum Reprod, 19, 41, 10.1093/humrep/deh098 · DOI · Paper page
  4. Sills, 2001, Diagnostic and treatment characteristics of polycystic ovary syndrome: descriptive measurements of patient perception and awareness from 657 confidential self-reports, BMC Women's Health, 1, 3, 10.1186/1472-6874-1-3 · DOI · Paper page
  5. Ndefo, 2013, Polycystic ovary syndrome: a review of treatment options with a focus on pharmacological approaches, P T, 38, 336
  6. Rutkowska, 2016, Polycystic ovary syndrome and environmental toxins, Fertil Steril, 106, 948, 10.1016/j.fertnstert.2016.08.031 · DOI · Paper page
  7. Mousa, 2020, Prevention and management of gestational diabetes using vitamin D supplementation: an overview and appraisal of applied sciences, Appl Sci, 10, 10.3390/app10228141 · DOI
  8. Mousa, 2017, 25-hydroxyvitamin D is associated with adiposity and cardiometabolic risk factors in a predominantly vitamin D-deficient and overweight/obese but otherwise healthy cohort, J Steroid Biochem Mol Biol, 173, 258, 10.1016/j.jsbmb.2016.12.008 · DOI
  9. Miao, 2020, Effect of vitamin D supplementation on polycystic ovary syndrome: a meta-analysis, Exp Ther Med, 19, 2641
  10. Guo, 2020, Vitamin D supplementation ameliorates metabolic dysfunction in patients with PCOS: a systematic review of RCTs and insight into the underlying mechanism, Int J Endocrinol, 2020, 1, 10.1155/2020/7850816 · DOI
  11. Gao, 2021, The effect of vitamin D supplementation on blood lipids in patients with polycystic ovary syndrome: a meta-analysis of randomized controlled trials, Int J Endocrinol, 2021, 1
  12. Nestler, 1998, Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system, J Clin Endocrinol Metab, 83, 2001
  13. Unfer, 2017, Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials, Endocrine Connections, 6, 647, 10.1530/EC-17-0243 · DOI · Paper page
  14. Unfer, 2016, Effects of inositol(s) in women with PCOS: a systematic review of randomized controlled trials, Int J Endocrinol, 2016, 1, 10.1155/2016/1849162 · DOI
  15. Montanino Oliva, 2018, Effects of myo-inositol plus alpha-lactalbumin in myo-inositol-resistant PCOS women, J Ovarian Res, 11, 38, 10.1186/s13048-018-0411-2 · DOI
  16. Greenberg, 2011, Folic acid supplementation and pregnancy: more than just neural tube defect prevention, Rev Obstet Gynecol, 4, 52
  17. Asbaghi, 2021, Effects of folic acid supplementation on oxidative stress markers: a systematic review and meta-analysis of randomized controlled trials, Antioxidants, 10, 871, 10.3390/antiox10060871 · DOI
  18. González, 2006, Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome, J Clin Endocrinol Metab, 91, 336, 10.1210/jc.2005-1696 · DOI · Paper page
  19. Kazerooni, 2008, Effect of folic acid in women with and without insulin resistance who have hyperhomocysteinemic polycystic ovary syndrome, Int J Gynecol Obstet, 101, 156, 10.1016/j.ijgo.2007.10.024 · DOI
  20. Guzelmeric, 2007, Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome, Gynecol Endocrinol, 23, 505, 10.1080/09513590701554306 · DOI
  21. Kilicdag, 2005, Administration of B-group vitamins reduces circulating homocysteine in polycystic ovarian syndrome patients treated with metformin: a randomized trial, Hum Reprod, 20, 1521, 10.1093/humrep/deh825 · DOI
  22. Bahmani, 2014, The effects of folate supplementation on inflammatory factors and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled clinical trial, Clin Endocrinol (Oxf), 81, 582, 10.1111/cen.12451 · DOI
  23. Asemi, 2014, Metabolic response to folate supplementation in overweight women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial, Mol Nutr Food Res, 58, 1465, 10.1002/mnfr.201400033 · DOI
  24. Loverro, 2002, The plasma homocysteine levels are increased in polycystic ovary syndrome, Gynecol Obstet Invest, 53, 157, 10.1159/000058367 · DOI
  25. Badawy, 2007, Plasma homocysteine and polycystic ovary syndrome: the missed link, Eur J Obstetr Gynecol Reprod Biol, 131, 68, 10.1016/j.ejogrb.2006.10.015 · DOI
  26. Yarali, 2001, Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome, Fertil Steril, 76, 511, 10.1016/S0015-0282(01)01937-9 · DOI · Paper page
  27. Kim, 2019, Association between metformin dose and vitamin B12 deficiency in patients with type 2 diabetes, Medicine (Baltimore), 98, 10.1097/MD.0000000000017918 · DOI · Paper page
  28. Bartstra, 2021, Six months vitamin K treatment does not affect systemic arterial calcification or bone mineral density in diabetes mellitus 2, Eur J Nutr, 60, 1691, 10.1007/s00394-020-02412-z · DOI
  29. Zoch, 2016, New insights into the biology of osteocalcin, Bone, 82, 42, 10.1016/j.bone.2015.05.046 · DOI · Paper page
  30. Schwalfenberg, 2017, Vitamins K1 and K2: the emerging group of vitamins required for human health, J Nutr Metab, 2017, 1, 10.1155/2017/6254836 · DOI · Paper page
  31. Tarkesh, 2020, Beneficial health effects of menaquinone-7 on body composition, glycemic indices, lipid profile, and endocrine markers in polycystic ovary syndrome patients, Food Sci Nutr, 8, 5612, 10.1002/fsn3.1837 · DOI
  32. Palamanda, 1993, Involvement of vitamin E and protein thiols in the inhibition of microsomal lipid peroxidation by glutathione, Lipids, 28, 427, 10.1007/BF02535941 · DOI
  33. Wang, 2004, Cosupplementation with vitamin E and coenzyme Q10 reduces circulating markers of inflammation in baboons, Am J Clin Nutr, 80, 649, 10.1093/ajcn/80.3.649 · DOI
  34. Cicek, 2012, Vitamin E effect on controlled ovarian stimulation of unexplained infertile women, J Assist Reprod Genet, 29, 325, 10.1007/s10815-012-9714-1 · DOI
  35. Izadi, 2019, Hormonal and metabolic effects of coenzyme Q10 and/or vitamin E in patients with polycystic ovary syndrome, J Clin Endocrinol Metab, 104, 319
  36. Ebrahimi, 2017, The effects of omega-3 fatty acids and vitamin E co-supplementation on indices of insulin resistance and hormonal parameters in patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial, Exp Clin Endocrinol Diabetes, 125, 353, 10.1055/s-0042-117773 · DOI
  37. Chen, 2020, Effect of a short-term vitamin E supplementation on oxidative stress in infertile PCOS women under ovulation induction: a retrospective cohort study, BMC Women's Health, 20, 69, 10.1186/s12905-020-00930-w · DOI
  38. Hahn, 2007, Retinol-binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism, Eur J Endocrinol, 157, 201, 10.1530/EJE-07-0143 · DOI · Paper page
  39. Tan, 2007, Raised serum, adipocyte, and adipose tissue retinol-binding protein 4 in overweight women with polycystic ovary syndrome: effects of gonadal and adrenal steroids, J Clin Endocrinol Metab, 92, 2764, 10.1210/jc.2007-0091 · DOI · Paper page
  40. Hosseini, 2021, Quercetin and metabolic syndrome: a review, Phytother Res, 35, 5352, 10.1002/ptr.7144 · DOI · Paper page
  41. Oh, 2014, Relationship between flavonoids intake and metabolic syndrome in Korean women with polycystic ovary syndrome, J Nutr Health, 47, 176, 10.4163/jnh.2014.47.3.176 · DOI
  42. Romualdi, 2008, Is there a role for soy isoflavones in the therapeutic approach to polycystic ovary syndrome? Results from a pilot study, Fertil Steril, 90, 1826, 10.1016/j.fertnstert.2007.09.020 · DOI
  43. Pourteymour Fard Tabrizi, 2020, Quercetin and polycystic ovary syndrome, current evidence and future directions: a systematic review, J Ovarian Res, 13, 11, 10.1186/s13048-020-0616-z · DOI
  44. Salehi, 2019, Insights on the use of alpha-lipoic acid for therapeutic purposes, Biomolecules, 9, 356, 10.3390/biom9080356 · DOI · Paper page
  45. Packer, 2010, Lipoic acid: energy metabolism and redox regulation of transcription and cell signaling, J Clin Biochem Nutr, 48, 26, 10.3164/jcbn.11-005FR · DOI · Paper page
  46. Prieto-Hontoria, 2013, Effects of lipoic acid on AMPK and adiponectin in adipose tissue of low- and high-fat-fed rats, Eur J Nutr, 52, 779, 10.1007/s00394-012-0384-7 · DOI
  47. Wang, 2010, alpha-Lipoic acid increases energy expenditure by enhancing adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor-gamma coactivator-1alpha signaling in the skeletal muscle of aged mice, Metabolism, 59, 967, 10.1016/j.metabol.2009.10.018 · DOI
  48. Masharani, 2010, Effects of controlled-release alpha lipoic acid in lean, nondiabetic patients with polycystic ovary syndrome, J Diabetes Sci Technol, 4, 359, 10.1177/193229681000400218 · DOI
  49. Haghighatdoost, 2019, Does alpha-lipoic acid affect lipid profile? A meta-analysis and systematic review on randomized controlled trials, Eur J Pharmacol, 847, 1, 10.1016/j.ejphar.2019.01.001 · DOI
  50. Cianci, 2015, d-chiro-Inositol and alpha lipoic acid treatment of metabolic and menses disorders in women with PCOS, Gynecol Endocrinol, 31, 483, 10.3109/09513590.2015.1014784 · DOI
  51. Vigerust, 2012, Free carnitine and acylcarnitines in obese patients with polycystic ovary syndrome and effects of pioglitazone treatment, Fertil Steril, 98, 1620, 10.1016/j.fertnstert.2012.08.024 · DOI
  52. Bene, 2018, Role of carnitine and its derivatives in the development and management of type 2 diabetes, Nutr Diabetes, 8, 8, 10.1038/s41387-018-0017-1 · DOI · Paper page
  53. Fenkci, 2008, Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome, Hum Reprod, 23, 1602, 10.1093/humrep/den109 · DOI
  54. Dunning, 2012, Promoting lipid utilization with l-carnitine to improve oocyte quality, Anim Reprod Sci, 134, 69, 10.1016/j.anireprosci.2012.08.013 · DOI
  55. Ringseis, 2012, Role of carnitine in the regulation of glucose homeostasis and insulin sensitivity: evidence from in vivo and in vitro studies with carnitine supplementation and carnitine deficiency, Eur J Nutr, 51, 1, 10.1007/s00394-011-0284-2 · DOI · Paper page
  56. Salehpour, 2019, Effects of L-carnitine on polycystic ovary syndrome, JBRA Assist Reprod, 23, 392
  57. 2020, Gynecol Endocrinol, 1
  58. 2020, J Psychosom Obstet Gynaecol, 41, I, 10.1080/0167482X.2020.1842508 · DOI
  59. Jamilian, 2017, Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial, Gynecol Endocrinol, 33, 442, 10.1080/09513590.2017.1290071 · DOI · Paper page
  60. Ashoush, 2016, Chromium picolinate reduces insulin resistance in polycystic ovary syndrome: randomized controlled trial, J Obstet Gynaecol Res, 42, 279, 10.1111/jog.12907 · DOI
  61. Jamilian, 2016, The effects of chromium supplementation on endocrine profiles, biomarkers of inflammation, and oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial, Biol Trace Elem Res, 172, 72, 10.1007/s12011-015-0570-6 · DOI
  62. Jamilian, 2018, The influences of chromium supplementation on glycemic control, markers of cardio-metabolic risk, and oxidative stress in infertile polycystic ovary syndrome women candidate for in vitro fertilization: a randomized, double-blind, placebo-controlled trial, Biol Trace Elem Res, 185, 48, 10.1007/s12011-017-1236-3 · DOI
  63. Fazelian, 2017, Chromium supplementation and polycystic ovary syndrome: a systematic review and meta-analysis, J Trace Elem Med Biol, 42, 92, 10.1016/j.jtemb.2017.04.008 · DOI
  64. Tang, 2018, Chromium supplementation in women with polycystic ovary syndrome: systematic review and meta-analysis, J Obstet Gynaecol Res, 44, 134, 10.1111/jog.13462 · DOI
  65. Kadoura, 2019, Effect of calcium and vitamin D supplements as an adjuvant therapy to metformin on menstrual cycle abnormalities, hormonal profile, and IGF-1 system in polycystic ovary syndrome patients: a randomized, placebo-controlled clinical trial, Adv Pharmacol Sci, 2019
  66. Panidis, 2005, Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome, Clin Chem, 51, 1691, 10.1373/clinchem.2005.052761 · DOI
  67. Hahn, 2006, Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome, Exp Clin Endocrinol Diabetes, 114, 577, 10.1055/s-2006-948308 · DOI · Paper page
  68. Szczuko, 2016, Quantitative assessment of nutrition in patients with polycystic ovary syndrome (PCOS), Rocz Panstw Zakl Hig, 67, 419
  69. Ahn, 2017, Calcium homeostasis in diabetes mellitus, J Vet Sci, 18, 261, 10.4142/jvs.2017.18.3.261 · DOI
  70. Gagnon, 2014, Effects of combined calcium and vitamin D supplementation on insulin secretion, insulin sensitivity and beta-cell function in multi-ethnic vitamin D-deficient adults at risk for type 2 diabetes: a pilot randomized, placebo-controlled trial, PLoS One, 9, 10.1371/journal.pone.0109607 · DOI
  71. van Dam, 2006, Dietary calcium and magnesium, major food sources, and risk of type 2 diabetes in U.S. black women, Diabetes Care, 29, 2238, 10.2337/dc06-1014 · DOI · Paper page
  72. Sun, 2005, Altered calcium homeostasis is correlated with abnormalities of fasting serum glucose, insulin resistance, and beta-cell function in the Newfoundland population, Diabetes, 54, 3336, 10.2337/diabetes.54.11.3336 · DOI · Paper page
  73. Voznesenskaya, 2015, Low-calcium diet prevents fructose-induced hyperinsulinemia and ameliorates the response to glucose load in rats, Nutr Metab, 12, 38, 10.1186/s12986-015-0035-0 · DOI
  74. Yim, 2008, Renin-angiotensin system – considerations for hypertension and kidney, Electrolyte Blood Press, 6, 42, 10.5049/EBP.2008.6.1.42 · DOI
  75. Belizan, 1984, The mediating role of the parathyroid gland in the effect of low calcium intake on blood pressure in the rat, Arch Latinoam Nutr, 34, 666
  76. Christakos, 2011, Vitamin D and intestinal calcium absorption, Mol Cell Endocrinol, 347, 25, 10.1016/j.mce.2011.05.038 · DOI · Paper page
  77. Foroozanfard, 2015, Calcium plus vitamin D supplementation influences biomarkers of inflammation and oxidative stress in overweight and vitamin D-deficient women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial, Clin Endocrinol (Oxf), 83, 888, 10.1111/cen.12840 · DOI
  78. Maktabi, 2018, Magnesium-zinc-calcium-vitamin D co-supplementation improves hormonal profiles, biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial, Biol Trace Elem Res, 182, 21, 10.1007/s12011-017-1085-0 · DOI
  79. Pal, 2012, Therapeutic implications of vitamin D and calcium in overweight women with polycystic ovary syndrome, Gynecol Endocrinol, 28, 965, 10.3109/09513590.2012.696753 · DOI
  80. Shokrpour, 2019, The effects of magnesium and vitamin E co-supplementation on hormonal status and biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome, Biol Trace Elem Res, 191, 54, 10.1007/s12011-018-1602-9 · DOI
  81. Tinggi, 2008, Selenium: its role as antioxidant in human health, Environ Health Prev Med, 13, 102, 10.1007/s12199-007-0019-4 · DOI · Paper page
  82. Qazi, 2018, Selenium, selenoproteins, and female reproduction: a review, Molecules, 23, 10.3390/molecules23123053 · DOI
  83. Mirone, 2013, Selenium and reproductive function. A systematic review, J Endocrinol Invest, 36, 28
  84. Coskun, 2013, Plasma selenium levels in Turkish women with polycystic ovary syndrome, Eur J Obstet Gynecol Reprod Biol, 168, 183, 10.1016/j.ejogrb.2013.01.021 · DOI
  85. Hajizadeh-Sharafabad, 2019, Selenium and polycystic ovary syndrome; current knowledge and future directions: a systematic review, Horm Metab Res, 51, 279, 10.1055/a-0890-6823 · DOI
  86. Maret, 2017, Zinc in cellular regulation: The nature and significance of “zinc signals”, Prev Nutr Food Sci, 22, 1, 10.3746/pnf.2017.22.1.1 · DOI
  87. Coulston, 1980, Insulin-like effect of zinc on adipocytes, Diabetes, 29, 665, 10.2337/diab.29.8.665 · DOI · Paper page
  88. Haase, 2003, Intracellular zinc fluctuations modulate protein tyrosine phosphatase activity in insulin/insulin-like growth factor-1 signaling, Exp Cell Res, 291, 289, 10.1016/S0014-4827(03)00406-3 · DOI · Paper page
  89. Guler, 2014, Zinc and homocysteine levels in polycystic ovarian syndrome patients with insulin resistance, Biol Trace Elem Res, 158, 297, 10.1007/s12011-014-9941-7 · DOI
  90. Jamilian, 2016, Effects of zinc supplementation on endocrine outcomes in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial, Biol Trace Elem Res, 170, 271, 10.1007/s12011-015-0480-7 · DOI
  91. Nasiadek, 2020, The role of zinc in selected female reproductive system disorders, Nutrients, 12, 10.3390/nu12082464 · DOI
  92. Shamasbi, 2020, The effect of probiotics, prebiotics, and synbiotics on hormonal and inflammatory indices in women with polycystic ovary syndrome: a systematic review and meta-analysis, Eur J Nutr, 59, 433, 10.1007/s00394-019-02033-1 · DOI
  93. Adriaens, 2006, Melatonin has dose-dependent effects on folliculogenesis, oocyte maturation capacity and steroidogenesis, Toxicology, 228, 333, 10.1016/j.tox.2006.09.018 · DOI · Paper page
  94. Tamura, 2009, Melatonin and the ovary: physiological and pathophysiological implications, Fertil Steril, 92, 328, 10.1016/j.fertnstert.2008.05.016 · DOI · Paper page
  95. Wei, 2013, Supplementation with low concentrations of melatonin improves nuclear maturation of human oocytes in vitro, J Assist Reprod Genet, 30, 933, 10.1007/s10815-013-0021-2 · DOI
  96. Sirotkin, 1997, Direct regulation of mammalian reproductive organs by serotonin and melatonin, J Endocrinol, 154, 1, 10.1677/joe.0.1540001 · DOI
  97. Hu, 2020, Melatonin application in assisted reproductive technology: a systematic review and meta-analysis of randomized trials, Front Endocrinol, 11, 160, 10.3389/fendo.2020.00160 · DOI
  98. Al-Q, 2018, Effect of melatonin supplementation on serum LH level and BMI in women with polycystic ovary syndrome, J Pharm Sci Res, 10, 1
  99. Poudyal, 2011, Omega-3 fatty acids and metabolic syndrome: effects and emerging mechanisms of action, Prog Lipid Res, 50, 372, 10.1016/j.plipres.2011.06.003 · DOI · Paper page
  100. Shahnazi, 2015, Influence of omega-3 fatty acid eicosapentaenoic acid on IGF-1 and COX-2 gene expression in granulosa cells of PCOS women, Iran J Reprod Med, 13, 71
  101. Meng, 2021, Anti-inflammatory action and mechanisms of resveratrol, Molecules (Basel, Switzerland), 26, 229, 10.3390/molecules26010229 · DOI · Paper page
  102. Shojaei-Zarghani, 2021, Resveratrol and markers of polycystic ovary syndrome: a systematic review of animal and clinical studies, Reprod Sci
  103. Amin, 2014, Novel coq10 antidiabetic mechanisms underlie its positive effect: modulation of insulin and adiponectine receptors, tyrosine kinase, PI3K, glucose transporters, sRAGE and visfatin in insulin resistant/diabetic rats, PLoS One, 9, 10.1371/journal.pone.0089169 · DOI
  104. Martelli, 2020, Coenzyme Q(4): clinical applications in cardiovascular diseases, Antioxidants, 9, 341, 10.3390/antiox9040341 · DOI
  105. Samimi, 2017, The effects of coenzyme Q10 supplementation on glucose metabolism and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial, Clin Endocrinol (Oxf), 86, 560, 10.1111/cen.13288 · DOI · Paper page
  106. Ruderman, 2013, AMPK, insulin resistance, and the metabolic syndrome, J Clin Invest, 123, 2764, 10.1172/JCI67227 · DOI · Paper page
  107. Mani, 2011, An open-label study on the effect of flax seed powder (Linum usitatissimum) supplementation in the management of diabetes mellitus, J Diet Suppl, 8, 257, 10.3109/19390211.2011.593615 · DOI · Paper page
  108. Haidari, 2020, The effects of flaxseed supplementation on metabolic status in women with polycystic ovary syndrome: a randomized open-labeled controlled clinical trial, Nutr J, 19, 8, 10.1186/s12937-020-0524-5 · DOI · Paper page
  109. Hou, 2019, Beneficial effects of pomegranate on lipid metabolism in metabolic disorders, Mol Nutr Food Res, 63
  110. Rom, 2017, Acrolein increases macrophage atherogenicity in association with gut microbiota remodeling in atherosclerotic mice: protective role for the polyphenol-rich pomegranate juice, Arch Toxicol, 91, 1709, 10.1007/s00204-016-1859-8 · DOI
  111. Esmaeilinezhad, 2020, The effect of synbiotics pomegranate juice on cardiovascular risk factors in PCOS patients: a randomized, triple-blinded, controlled trial, J Endocrinol Invest, 43, 539, 10.1007/s40618-019-01139-x · DOI
  112. Esmaeilinezhad, 2019, Effect of synbiotic pomegranate juice on glycemic, sex hormone profile and anthropometric indices in PCOS: a randomized, triple blind, controlled trial, Nutr Metab Cardiovasc Dis, 29, 201, 10.1016/j.numecd.2018.07.002 · DOI
  113. Martinez-Garcia, 2009, Body iron stores and glucose intolerance in premenopausal women: role of hyperandrogenism, insulin resistance, and genomic variants related to inflammation, oxidative stress, and iron metabolism, Diabetes Care, 32, 1525, 10.2337/dc09-0420 · DOI
  114. Escobar-Morreale, 2012, Iron metabolism and the polycystic ovary syndrome, Trends Endocrinol Metab, 23, 509, 10.1016/j.tem.2012.04.003 · DOI
  115. Luque-Ramirez, 2007, Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses, Diabetes Care, 30, 2309, 10.2337/dc07-0642 · DOI
  116. Medagama, 2015, The glycaemic outcomes of cinnamon, a review of the experimental evidence and clinical trials, Nutr J, 14, 108, 10.1186/s12937-015-0098-9 · DOI · Paper page
  117. Ong, 2017, Chinese herbal medicine for the optimal management of polycystic ovary syndrome, Am J Chin Med, 45, 405, 10.1142/S0192415X17500252 · DOI
  118. Chang, 2016, Evaluation of the in vivo therapeutic effects of radix paeoniae rubra ethanol extract with the hypoglycemic activities measured from multiple cell-based assays, Evid Based Complement Alternat Med, 2016, 10.1155/2016/3262790 · DOI
  119. Zhou, 2016, Chinese herbal medicine for subfertile women with polycystic ovarian syndrome, Cochrane Database Syst Rev, 10
  120. Zhang, 2013, Curcumin and diabetes: a systematic review, Evid Based Complement Alternat Med, 2013, 10.1155/2013/636053 · DOI · Paper page
  121. Ghowsi, 2020, Effects of Salvia officinalis L. (common sage) leaves tea on insulin resistance, lipid profile, and oxidative stress in rats with polycystic ovary: an experimental study, Avicenna J Phytomed, 10, 263
  122. Badgujar, 2014, Biomed Res Int, 2014, 10.1155/2014/842674 · DOI · Paper page
  123. Sadeghi Ataabadi, 2017, Role of essential oil of Mentha spicata (Spearmint) in addressing reverse hormonal and folliculogenesis disturbances in a polycystic ovarian syndrome in a rat model, Adv Pharm Bull, 7, 651, 10.15171/apb.2017.078 · DOI
  124. Chen, 2012, Protective effects of sweet orange (Citrus sinensis) peel and their bioactive compounds on oxidative stress, Food Chem, 135, 2119, 10.1016/j.foodchem.2012.07.041 · DOI
  125. Ali, 2008, Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale roscoe): a review of recent research, Food Chem Toxicol, 46, 409, 10.1016/j.fct.2007.09.085 · DOI · Paper page
  126. Ainehchi, 2019, Biomolecules, 9, 215, 10.3390/biom9060215 · DOI
  127. Zhang, 2017, Acupuncture for the treatment of obesity in adults: a systematic review and meta-analysis, Postgrad Med J, 93, 743, 10.1136/postgradmedj-2017-134969 · doi:10.1136/postgradmedj-2017-134969
  128. Richards, 1998, Stimulation of auricular acupuncture points in weight loss, Aust Fam Physician, 27, S73
  129. Li, 2015, Effects and mechanisms of auricular vagus nerve stimulation on high-fat-diet-induced obese rats, Nutrition, 31, 1416, 10.1016/j.nut.2015.05.007 · DOI
  130. Firouzjaei, 2016, Comparative evaluation of the therapeutic effect of metformin monotherapy with metformin and acupuncture combined therapy on weight loss and insulin sensitivity in diabetic patients, Nutr Diabetes, 6, e209, 10.1038/nutd.2016.16 · DOI
  131. Gucel, 2012, Influence of acupuncture on leptin, ghrelin, insulin and cholecystokinin in obese women: a randomised, sham-controlled preliminary trial, Acupunct Med, 30, 203, 10.1136/acupmed-2012-010127 · DOI
  132. Hsu, 2009, The effect of auricular acupuncture in obese women: a randomized controlled trial, J Women's Health, 18, 813, 10.1089/jwh.2008.1005 · DOI
  133. Lin, 2014, Acupoint-specific, frequency-dependent, and improved insulin sensitivity hypoglycemic effect of electroacupuncture applied to drug-combined therapy studied by a randomized control clinical trial, Evid Based Complement Alternat Med, 2014, 10.1155/2014/371475 · DOI
  134. Lin, 2011, Electroacupuncture improves glucose tolerance through cholinergic nerve and nitric oxide synthase effects in rats, Neurosci Lett, 494, 114, 10.1016/j.neulet.2011.02.071 · DOI
  135. Lin, 2009, Acute effect of electroacupuncture at the Zusanli acupoints on decreasing insulin resistance as shown by lowering plasma free fatty acid levels in steroid-background male rats, BMC Complement Altern Med, 9, 26, 10.1186/1472-6882-9-26 · DOI
  136. Liang, 2010, Acupuncture: is it effective for treatment of insulin resistance?, Diabetes Obes Metab, 12, 555, 10.1111/j.1463-1326.2009.01192.x · DOI
  137. Peplow, 2012, Electroacupuncture for control of blood glucose in diabetes: literature review, J Acupunct Meridian Stud, 5, 1, 10.1016/j.jams.2011.11.018 · DOI
  138. Wang, 2008, Electroacupuncture in the treatment of obesity, Neurochem Res, 33, 2023, 10.1007/s11064-008-9822-6 · DOI
  139. Stener-Victorin, 2008, Acupuncture in polycystic ovary syndrome: current experimental and clinical evidence, J Neuroendocrinol, 20, 290, 10.1111/j.1365-2826.2007.01634.x · DOI
  140. Stener-Victorin, 2006, Ovarian blood flow responses to electroacupuncture stimulation depend on estrous cycle and on site and frequency of stimulation in anesthetized rats, J Appl Physiol (Bethesda, MD: 2006), 101, 84, 10.1152/japplphysiol.01593.2005 · DOI
  141. Wu, 2020, Effectiveness of acupuncture in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials, Medicine (Baltimore), 99, 10.1097/MD.0000000000020441 · DOI
  142. Qu, 2016, The effects of acupuncture on polycystic ovary syndrome: a systematic review and meta-analysis, Eur J Integr Med, 8, 12, 10.1016/j.eujim.2016.02.001 · DOI
  143. Monro, 1997, Yoga therapy, J Bodyw Mov Ther, 1, 215, 10.1016/S1360-8592(97)80047-2 · DOI
  144. Shele, 2020, A systematic review of the effects of exercise on hormones in women with polycystic ovary syndrome, J Funct Morphol Kinesiol, 5, 35, 10.3390/jfmk5020035 · DOI · Paper page
  145. Verma, 2021, Effect of yoga therapy on health outcomes in women with polycystic ovary syndrome: a systematic review and meta-analysis, Am J Lifestyle Med
  146. Thakur, 2021, Effect of yoga on polycystic ovarian syndrome: a systematic review, J Bodyw Mov Therap, 27, 281, 10.1016/j.jbmt.2021.02.018 · DOI
  147. Mohseni, 2021, Yoga effects on anthropometric indices and polycystic ovary syndrome symptoms in women undergoing infertility treatment: a randomized controlled clinical trial, Evid Based Complement Alternat Med, 2021, 10.1155/2021/5564824 · DOI
  148. Selvaraj, 2020, Impact of yoga and exercises on polycystic ovarian syndrome risk among adolescent schoolgirls in South India, Health Sci Rep, 3, e212, 10.1002/hsr2.212 · DOI
  149. Stefanaki, 2015, Impact of a mindfulness stress management program on stress, anxiety, depression and quality of life in women with polycystic ovary syndrome: a randomized controlled trial, Stress (Amsterdam, Netherlands), 18, 57, 10.3109/10253890.2014.974030 · DOI
  150. Gupta, 2017, Interactions between antidiabetic drugs and herbs: an overview of mechanisms of action and clinical implications, Diabetol Metab Syndr, 9, 59, 10.1186/s13098-017-0254-9 · DOI · Paper page

Cited by

Metadata

Authors
Alesi, S., Ee, C., Moran, L. J., Rao, V., & Mousa, A.
Venue
Advances in Nutrition
Publisher
Elsevier BV
Published
2022-07
Volume
13
Issue
4
Pages
1243-1266
ISSN
  • 2156-5376 (ISSN-L)
  • 2161-8313
OpenAlex
W4207014251
Cited by
146
References
47
FWCI
13.03
Type
journal article
Language
en
Open access
bronze
Licence
Funders
  • Monash University
  • National Heart Foundation
  • Jacka Foundation of Natural Therapies
  • National Health and Medical Research Council

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.